EN

Menu

Press Releases

View:

Date

Title

Jun 24, 2015

Important Safety Information on the Recall of Mylan Piperacillin-Tazobactam for Injection, 3 g/0.375 g and 4 g/0.5 g Which May Contain Particulate Matter

Jun 24, 2015
Mar 16, 2015

Important Safety Information on Recall of Lots of Three (3) Mylan Products for Injection Which May Contain Foreign Particulate Matter: Cisplatin Injection 1 mg/mL, Gemcitabine for Injection, USP 1g and 2 g per vial, and Topotecan HCl for Injection 4 mg per vial

Mar 16, 2015
Mar 12, 2015

Important Safety Information on Methotrexate Injection USP 50mg/2mL by Mylan Which May Contain Foreign Particulate Matter

Mar 12, 2015
Mar 12, 2015

Important Safety Information on Methotrexate Injection USP 50mg/2mL by Mylan Which May Contain Foreign Particulate Matter

Mar 12, 2015
Jan 20, 2015

Health Canada Endorsed Important Safety Information on domperidone maleate

Jan 20, 2015
Jan 20, 2015

Public Communication - Health Canada Endorsed Important Safety Information on domperidone maleate

Jan 20, 2015
Jan 01, 2015

Building a Team of Athletes to Run Across Canada in Support of HIV/AIDS

Jan 01, 2015
Dec 01, 2014

Mylan and Canadian AIDS Society Team up in Cross-Country Relay to Accelerate Canada’s Fight Against HIV/AIDS

Dec 01, 2014
Oct 30, 2014

Mylan-Atorvastatin: New Product Appearance, DINs and UPC Codes

Oct 30, 2014

Topic: products
Oct 30, 2014

Update for Mylan-Nitro Sublingual Spray 0.4 mg Per Metered Dose (DIN: 02243588) – Unaffected Product Has Now Become Available.

Oct 30, 2014

Topic: products

Company

Products

Businesses

News

Investors

Careers

Resources and information to help prescribe, dispense and take medicine with confidence

Pharmacists

Educational materials to help empower your customers.
Patients

What to know about our high quality generics.
Physicians

Details about our brand name and generic medicines.

Explore

Copyright © 2015 Mylan Pharmaceuticals ULC. A Company of Mylan N.V.

For CA Audiences Only